看多
Cleveland BioLabs is at the bottom of the weekly box
Despite reporting $1.9 million net loss for the second quarter of 2016 technical analysis stipulates the shares of the company would at least double its value.
The point is that there was a bullish engulfing at the bottom of a significant rectangle which lasts more than a year. Moreover RSI(5) analysis implies divergence which coupled with double bottom increases the chances a winning trade.
For more ideas visit mercurius.wordpress.com
The point is that there was a bullish engulfing at the bottom of a significant rectangle which lasts more than a year. Moreover RSI(5) analysis implies divergence which coupled with double bottom increases the chances a winning trade.
For more ideas visit mercurius.wordpress.com
免責聲明
這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。